Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 30%
Sell 10%
Strong Sell 0%

Bulls say

Alcon is a leading company in the vision care market with a strong portfolio in contact lenses, lens care solutions, and ocular health products, as well as in surgical equipment and devices for cataract, glaucoma, and refractive eye surgeries. Management expects continued growth in revenue and earnings, driven by new product launches and strong customer demand. The company has strong financials and a solid operating margin. Potential upside drivers include new lens products and an expanding ophthalmic eye drop portfolio, while risks include weaker-than-expected market growth and competition in various business segments. Our investment thesis is that Alcon can sustain mid-single digit revenue growth or better, and we believe the stock is undervalued at its current price.

Bears say

Alcon is seeing decent top-line growth but margin expansion remains a concern due to tougher upcoming comps, tariff impacts, and increased operating spend. While the company is investing heavily in research and development and has a strong product pipeline, the sustainability of this growth remains to be seen in the currently competitive and rapidly changing eyecare market.

ALC has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 10 analysts, ALC has a Buy consensus rating as of Sep 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.